082800 Stock Chart & Stats
₩2345.00
₩165.00(7.57%)
―
--
Day’s Range― - ―
52-Week Range₩2,070.00 - ₩7,964.87
Previous CloseN/A
VolumeN/A
Average Volume (3M)792.83K
Market Cap
₩141.09B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding60,719,666
10 Day Avg. Volume259,162
30 Day Avg. Volume792,828
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
082800 FAQ
What was VIVOZON PHARMACEUTICAL CO., LTD.’s price range in the past 12 months?
VIVOZON PHARMACEUTICAL CO., LTD. lowest stock price was ₩2070.00 and its highest was ₩7964.87 in the past 12 months.
What is VIVOZON PHARMACEUTICAL CO., LTD.’s market cap?
VIVOZON PHARMACEUTICAL CO., LTD.’s market cap is ₩141.09B.
When is VIVOZON PHARMACEUTICAL CO., LTD.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VIVOZON PHARMACEUTICAL CO., LTD.’s earnings last quarter?
VIVOZON PHARMACEUTICAL CO., LTD. released its earnings results on May 15, 2026. The company reported -₩106.599 earnings per share for the quarter, missing the consensus estimate of N/A by -₩106.599.
Is VIVOZON PHARMACEUTICAL CO., LTD. overvalued?
According to Wall Street analysts VIVOZON PHARMACEUTICAL CO., LTD.’s price is currently Undervalued.
Does VIVOZON PHARMACEUTICAL CO., LTD. pay dividends?
VIVOZON PHARMACEUTICAL CO., LTD. does not currently pay dividends.
What is VIVOZON PHARMACEUTICAL CO., LTD.’s EPS estimate?
VIVOZON PHARMACEUTICAL CO., LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VIVOZON PHARMACEUTICAL CO., LTD. have?
VIVOZON PHARMACEUTICAL CO., LTD. has 60,719,666 shares outstanding.
What happened to VIVOZON PHARMACEUTICAL CO., LTD.’s price movement after its last earnings report?
VIVOZON PHARMACEUTICAL CO., LTD. reported an EPS of -₩106.599 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.213%.
Which hedge fund is a major shareholder of VIVOZON PHARMACEUTICAL CO., LTD.?
Currently, no hedge funds are holding shares in KR:082800
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dong Wha Pharm Co., Ltd.
―
Samil Pharmaceutical Co., Ltd.
―
KYUNG DONG PHARMACEUTICAL Co., Ltd
―
Jeil Pharmaceutical Co. Ltd.
―
Hana Pharm Co., Ltd.
―